first case holds more weight and that's the exact scenario that we have here we have defendants making extremely positive statements while not only yet failing to disclose any of it to be a significant continued to rest below pretty july twenty fourth state the reason for that is when you go through the press release it makes the  was made in the meeting minutes or a briefing document two or three years later that relates to something that's right there was allegedly told in july two thousand and thirteen that statement is go following as it really is the the twelve patients and we also indicated that we might you know we get support from the patients themselves for the boys to go into surgery fourth time we were concerned at that point if we had to do that burn that's putting independent verification of or will submit them directly to you for you to review which which we did which we ultimately did let's do it that way instead of having a fourth biopsy but let's work on that that was only flocks of it and that's exactly what which is the company's sponsors who are trying to work through this process especially in this context where we're seeking were totally run charter territory and we're seeking accelerated approval on an unmet disease and we're we're for in this is exactly what we're saying critically after we after we relate all this to the market the stock didn't move at all and the reason for that it they say they treat this as if there were some kind of bo here or some kind of seeking adverse events or those kinds of things that are typically held back in these kinds of cases these are not bombs this is a normal back and forth and homilies subsume within in july press release we covered this around with the with our investors and we told them there is a lot of wood to chop here a lot of work to do it's going to take a year we don't know exactly what work they're going to make us do but it is obvious that our current presentation of the destruction is not enough that's why we have to keep getting them over the hump that's what we told them on july twenty fourth when we got more detail we told them that in september the stock did not move at all when they stopped and it was not that there's some bomber to say but hey we told you in july that we were open to considering an n d a on the basis of dystrophin that might be premature we need to learn more about this and we disclose that to the market right we have told them they're open to he's the number two individual at the company so they argue that the number one individual in the number three individual near but not the number two i would say the executives at the company know what's happening with the f d a on the one drug that might certainly in this it has been deemed insufficient as a matter of law to establish c enter it is particularly the case here where we have an apple market offering so it's not a one burst offering where you're going to get an influx of cash or a one time a market offering is a year on the rush why don't you go and tell the brokers to to sell stock when there's a pigeon to man for it sometimes these things take months in fact they always take months sometimes they take six to twelve months